
New COVID-19 Drug Shows Greater Promise Against Resistant Viral Strains
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment. As with its predecessor, the new drug candidate, Jun13296, targets a …